Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
IMM Announcements
Immutep receives FDA ODD for Efti in…
IMM
IMMUTEP LIMITED
Market sensitive
Immutep receives FDA ODD for Efti in Soft Tissue Sarcoma
Date and time
15 April 2026 at 7:27 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
IMM announcement history
Recent IMM announcements
Immutep Corporate Presentation
Immutep Quarterly Activities Report and Appendix 4C
Abstract Accepted for Presentation at ESMO Congress 2026
Fourth U.S. Patent Secured for Efti and PD-1 Combination
TACTI-004 Update & Positive Mature Data from INSIGHT-003
Ceasing to be a substantial holder